Conditions: BRAF V600E Negative; KRAS Gene Mutation Negative; Locally Advanced Unresectable Colorectal Adenocarcinoma; Metastatic Colorectal Adenocarcinoma; NRAS Gene Mutation Negative; Stage III Colorectal Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8...
Mon Oct 07, 2019 15:07
Condition: Advanced Prostate Cancer Intervention: Diagnostic Test: WB-MRI Sponsors: Royal Marsden NHS Foundation Trust; National Institute for Health Research, United Kingdom; Institute of Cancer Research, United Kingdom Recruiting (Source: ClinicalTrials.gov)
Mon Oct 07, 2019 15:07
Conditions: Breast Cancer Female; Alopecia Interventions: Device: Paxman Scalp Cooling System; Other: Alopecia Assessments Sponsor: Medical University Innsbruck Recruiting (Source: ClinicalTrials.gov)
Mon Oct 07, 2019 15:07
DiscussionThis trial will assess the feasibility and effectiveness of patient-collected family health history linked to decision support to promote risk-appropriate screening in a large healthcare system such as the Department of Veterans Affairs.Trial registrationClinicalTrials.gov,NCT02247336. Registered on 25 September 2014. (Source: Trials)
Mon Oct 07, 2019 00:00
ConclusionsLEARN|INFORM|RECRUIT is a promising implementation intervention to address low accrual to clinical trials, poised for implementation and effectiveness testing. The implementation intervention is appealing to its target audience and may have equal uptake among trial-na ïve and trial-experienced practices. (Source: Trials)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained...
Mon Oct 07, 2019 00:00
Conditions: Metastatic Uveal Melanoma; Triple Negative Breast Cancer; Luminal B Breast Cancer; Pediatric Cancer Interventions: Behavioral: Questionnaires; Behavioral: Semi-structured individual interviews; Other: Focus Group; Other: DELPHI Consensus Method Sponsor: Institut Curie Not yet recruiting (Source: ClinicalTrials.gov)
Sun Oct 06, 2019 16:36
Conditions: Castration-Resistant Prostatic Cancer; Metastatic Disease Intervention: Drug: 111In-DOTA-h11B6 Sponsors: Tomopath Inc.; Invicro; Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: Breast Neoplasm Female; Lymphatic Metastasis Intervention: Procedure: Radiotherapy Sponsors: Kyungpook National University Chilgok Hospital; Korean Breast Cancer Study Group Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Fri Oct 04, 2019 18:00
Condition: Breast Cancer Interventions: Other: PECS block; Other: Local infiltration Sponsors: Hôpital du Valais; University of Lausanne Hospitals Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: Melanoma; Breast Cancer; Merkel Cell Carcinoma; Squamous Cell Cancer; Non Small Cell Lung Cancer; Cervical Cancer; Urothelial Carcinoma; Ovarian Cancer; Hepatocellular Carcinoma; Small-cell Lung Cancer; Microsatellite Instability High; Gastric C ancer; Esophageal Cancer Interventions: Device: Echopulse; Drug: Imiquimod; Drug: Standard of Care PD-1 Therapy Sponsors: Craig L Slingluff, Jr; Theraclion Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: Metastatic Breast Cancer; Triple Negative Breast Cancer Intervention: Drug: PMD-026 Sponsor: Phoenix Molecular Designs Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: Esophageal Squamous Cell Carcinoma Intervention: Radiation: Simultaneous integrated boost intensity-modulated chemoradiotherapy Sponsor: Fudan University Recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: Malignant Solid Tumor Interventions: Drug: HDM201; Drug: Ribociclib; Drug: Cabozantinib Sponsor: Centre Leon Berard Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Fri Oct 04, 2019 18:00
Condition: Polycythemia Vera Interventions: Drug: Ruxolitinib; Drug: Hydroxycarbamide; Drug: Interferon-Alpha Sponsors: University of Birmingham; Novartis; MPN Voice; National Cancer Institute, France Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: Metastatic NUT Carcinoma; Unresectable NUT Carcinoma Interventions: Drug: Cisplatin; Drug: Etoposide; Drug: Etoposide Phosphate; Drug: Molibresib; Drug: Molibresib Besylate Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Fri Oct 04, 2019 18:00
Condition: Breast Cancer Intervention: Other: Rehabilitation after breast cancer surgery Sponsor: Universidade Federal de Sao Carlos Recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: DERMATITIS INDUCED BY RADIOTHERAPY IN PATIENTS WHITH CANCER Interventions: Combination Product: Cosmetic cream (Alantel (R): aloe vera, chamomile and thime); Combination Product: Placebo Sponsor: Hospital Universitario Reina Sofia de Cordoba Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: Prostate Cancer Intervention: Diagnostic Test: Prostate Biopsy Test Sponsor: Sheba Medical Center Recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: Oropharyngeal Cancer Interventions: Drug: Cisplatin; Drug: Durvalumab; Procedure: Radiotherapy; Procedure: Dose-escalated radiotherapy Sponsors: University of Birmingham; AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: Cancer; Radiotherapy Side Effect Intervention: Radiation: Radiotherapy Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Fri Oct 04, 2019 18:00
Conditions: Carcinoma, Non-Small-Cell Lung; Immune-Related Adverse Events Interventions: Drug: PD-1 inhibitor; Drug: Chemotherapy Drugs, Cancer Sponsors: Sungkyunkwan University; Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: Blood Loss, Surgical Intervention: Diagnostic Test: Quantra System Sponsor: HemoSonics LLC Enrolling by invitation (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: CCND1 Positive; Liver Lymphoma; Mantle Cell Lymphoma; t(11;14) Positive Interventions: Drug: Acalabrutinib; Drug: Bendamustine; Drug: Bendamustine Hydrochloride; Drug: Cytarabine; Biological: Rituximab Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Conditions: Pancreatic Cancer Non-resectable; Pancreatic Cancer Metastatic Intervention: Drug: INCMGA00012 (PD-1 antibody) Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Fri Oct 04, 2019 18:00
Condition: Prostate Cancer Intervention: Device: Biomedical TATO3® Microwave needle thermoablation device (Koelis, Grenoble, France) Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Thu Oct 03, 2019 18:00
Conditions: Melanoma; Renal Cell Carcinoma; NSCLC; Hepatocellular Carcinoma; Urothelial Cancer; Gastric Adenocarcinoma; HNSCC; Esophageal Adenocarcinoma; Microsatellite Instability-High Solid Malignant Tumor Interventions: Drug: Nivolumab or Pembrolizumab (dependent upon approved indication); Drug: Metformin; Drug: Rosiglitazone Sponsor: Dan Zandberg Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 03, 2019 18:00
Condition: Prostate Cancer Recurrent Interventions: Biological: RV001V; Other: Placebo Sponsor: RhoVac APS Recruiting (Source: ClinicalTrials.gov)
Thu Oct 03, 2019 18:00
Condition: Brain Cancer Interventions: Device: 3D-printed mask; Device: Thermoplastic mask Sponsor: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Thu Oct 03, 2019 18:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου